13th February 2026, Friday

TechPharus

Latest Posts

HealthTech News

  • Broken legs, skier’s thumb and ‘sled head’: Just some of the injuries risked by Winter Olympians
    on February 13, 2026 at 8:50 pm

    The sports featured at the Winter Olympics defy gravity and physics. Many competitors move at breakneck speeds down steep, snowy inclines or careen across icy surfaces in a bid to set world records and earn their place on the podium.

  • Men lose their Y chromosome as they age: Scientists thought it didn’t matter—but now we’re learning more
    on February 13, 2026 at 8:40 pm

    Men tend to lose the Y chromosome from their cells as they age. But because the Y bears few genes other than for male determination, it was thought this loss would not affect health. But evidence has mounted over the past few years that when people who have a Y chromosome lose it, the loss is associated with serious diseases throughout the body, contributing to a shorter lifespan.

  • SSRI medications during pregnancy may increase risk of gestational diabetes but protect against preterm birth
    on February 13, 2026 at 8:00 pm

    An international team of researchers has found that the use of selective serotonin reuptake inhibitor (SSRI) antidepressants during pregnancy is associated with an increased risk of gestational diabetes and early adaptation problems in newborns, even after taking maternal depression into account. The study also discovered that taking SSRI medication during pregnancy may reduce the risks of preterm birth and low birth weight. The work is published in the American Journal of Obstetrics & Gynecology MFM.

  • False alarm in newborn screening: How zebrafish can prevent unnecessary spinal muscular atrophy therapies
    on February 13, 2026 at 7:20 pm

    A positive newborn screening for spinal muscular atrophy (SMA) is currently considered a medical emergency. Without early treatment, severe disability or death in infancy are likely. However, research findings from Germany and Australia now show that in rare cases, a positive screening result can be a genetic false alarm. Researchers have discovered that functional tests in a zebrafish model may enable fast and reliable clinical decision-making in cases of unclear genetic findings.

  • Study identifies a new class of drug targets for aggressive leukemia
    on February 13, 2026 at 7:06 pm

    Hyperactive signaling pathways of some aggressive blood cancer cells can be tamped down by a previously unrecognized protein complex, ensuring the cancer’s survival. If one component of the complex is deleted or removed, the cancer cells are sent into overdrive and die, finds a Yale-led study published in Science Signaling.